Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes

Aim: The aim of this study was to examine the efficacy and safety of topiramate as an adjunct to diet and exercise in drug‐naive, obese subjects with type 2 diabetes. Methods: Drug‐naive individuals with type 2 diabetes, body mass index (BMI) of ≥27 and

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes, obesity & metabolism obesity & metabolism, 2007-05, Vol.9 (3), p.360-368
Hauptverfasser:	Stenlöf, K., Rössner, S., Vercruysse, F., Kumar, A., Fitchet, M., Sjöström, L.
Format:	Artikel
Sprache:	eng
Schlagworte:	adverse effects Albuminuria Albuminuria - complications analogs & derivatives analysis Anti-Obesity Agents Anti-Obesity Agents - adverse effects Anti-Obesity Agents - therapeutic use Blood Glucose Blood Glucose - analysis Blood Pressure Blood Pressure - drug effects chemically induced complications Diabetes Mellitus Diabetes Mellitus, Type 2 - complications diabetic Double-Blind Method drug effects drug therapy Endocrinology and Diabetes Endokrinologi och diabetes Female Fructose Fructose - adverse effects Fructose - analogs & derivatives Fructose - therapeutic use glycaemic control Glycated Hemoglobin A - analysis Glycosylated Hemoglobin A Humans lifestyle Lipid Metabolism Lipid Metabolism - drug effects Male Middle Aged Nervous System Diseases Nervous System Diseases - chemically induced Obesity Obesity - complications Obesity - drug therapy therapeutic use topiramate Treatment Outcome Type 2 Weight Loss Weight Loss - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Aim: The aim of this study was to examine the efficacy and safety of topiramate as an adjunct to diet and exercise in drug‐naive, obese subjects with type 2 diabetes. Methods: Drug‐naive individuals with type 2 diabetes, body mass index (BMI) of ≥27 and
ISSN:	1462-8902 1463-1326
DOI:	10.1111/j.1463-1326.2006.00618.x